TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05924360

Intervention type: OTHER
Group type: OTHER
Intervention: conventional exercise program
Description: The conventional treatment program will be applied to all participants included in the study, consisting of wand, codman, active and passive stretching exercises. This program will be administered to all patients five days a week. Wand exercises will be applied in the directions of flexion, abduction, extension, internal and external rotation, and will consist of 10 repetitions. Codman exercises will be applied in the directions of flexion, abduction, and circular, and will also consist of 10 repetitions. Active and passive stretching exercises will be applied in the directions of flexion, abduction, and external rotation, and will consist of 10 repetitions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional exercise program
Description: The conventional treatment program will be applied to all participants included in the study, consisting of wand, codman, active and passive stretching exercises. This program will be administered to all patients five days a week. Wand exercises will be applied in the directions of flexion, abduction, extension, internal and external rotation, and will consist of 10 repetitions. Codman exercises will be applied in the directions of flexion, abduction, and circular, and will also consist of 10 repetitions. Active and passive stretching exercises will be applied in the directions of flexion, abduction, and external rotation, and will consist of 10 repetitions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional exercise program
Description: The conventional treatment program will be applied to all participants included in the study, consisting of wand, codman, active and passive stretching exercises. This program will be administered to all patients five days a week. Wand exercises will be applied in the directions of flexion, abduction, extension, internal and external rotation, and will consist of 10 repetitions. Codman exercises will be applied in the directions of flexion, abduction, and circular, and will also consist of 10 repetitions. Active and passive stretching exercises will be applied in the directions of flexion, abduction, and external rotation, and will consist of 10 repetitions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan application
Description: The mobilization with movement technique, a part of Mulligan applications, will be performed twice a week in the directions of flexion, abduction, and external rotation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Maitland application
Description: Maitland Group: The Maitland application will be applied in the anterior-posterior, posterior-anterior, and caudal directions. The Maitland application will be administered at grades 2-3. Patients in this group will receive the application in five sets of 30 seconds, twice a week.

Intervention type: DEVICE
Group type: OTHER
Intervention: TENS
Description: TENS application will be administered for 20 minutes at 100Hz
Study: NCT04913324

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Care
Description: Infants randomized at 4 months of age to the intervention arm will participate in virtual care visits for 16 weeks in addition to standard of care in-hospital visits.
Study: NCT05018429

Intervention type: PROCEDURE
Intervention: nerve sparing
Description: When resect the bladder and prostate, the neurovascular bundles around the prostate will be preserved.
Study: NCT05886803

Intervention type: OTHER
Intervention: Spontaneous ventilation test
Description: The purpose is to mimic ventilation conditions after extubation and thus to help the clinician predict the outcome of an extubation decision.

Intervention type: OTHER
Intervention: Spontaneous ventilation test
Description: The purpose is to mimic ventilation conditions after extubation and thus to help the clinician predict the outcome of an extubation decision.
Study: NCT05059262

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: vimseltinib
Description: CSF1R inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vimseltinib
Description: CSF1R inhibitor

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05716490

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy
Description: Application of negative pressure wound therapy for prophylaxis of surgical site occurrences

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy
Description: Application of negative pressure wound therapy for prophylaxis of surgical site occurrences

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group - standard wound dressing
Description: Covering of surgical wound with standard wound dressing
Study: NCT05166928

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: carriere motion appliance
Description: after finished treatment with carrirere motion appliance in the two group (group 1 have upper wisdom teeth ,group 2 have not upper wisdom teeth ) the pre and post casts will be scanned and superimposed to determine amount upper molar distalization

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: carriere motion appliance
Description: after finished treatment with carrirere motion appliance in the two group (group 1 have upper wisdom teeth ,group 2 have not upper wisdom teeth ) the pre and post casts will be scanned and superimposed to determine amount upper molar distalization
Study: NCT05172310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI-46
Description: * \[68Ga\] Ga-FAPI-46 Solution for Injection is manufactured at the Karolinska University Hospital Radiopharmacy facilities, for imaging studies with Positron Emission Tomography (PET).~* It is a radiolabelled Fibroblast Activation Protein Inhibitor (FAPI) used for PET of a number of different cancer entities.~* Depending on the labelling yield 50 - 370 megabecquerel (MBq) of \[68Ga\] Ga-FAPI-46 Solution for Injection will be administered intravenously 60 minutes prior to whole-body PET image acquisition.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 68Ga-FAPI-46
Description: * \[68Ga\] Ga-FAPI-46 Solution for Injection is manufactured at the Karolinska University Hospital Radiopharmacy facilities, for imaging studies with Positron Emission Tomography (PET).~* It is a radiolabelled Fibroblast Activation Protein Inhibitor (FAPI) used for PET of a number of different cancer entities.~* Depending on the labelling yield 50 - 370 megabecquerel (MBq) of \[68Ga\] Ga-FAPI-46 Solution for Injection will be administered intravenously 60 minutes prior to whole-body PET image acquisition.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET/CT
Description: * Combined PET and computed tomography (CT) imaging with 68Ga-FAPI-46 will be performed using the same protocol on a Biograph 6 PET/CT scanner (Siemens, Erlangen, Germany) and General Electrics (GE) Discovery 710, Milwaukee, Wisconsin, USA at the Department of Nuclear Medicine, Karolinska Huddinge within 2 weeks before surgery.~* PET/CT imaging will be performed in dynamic mode at one bed position centered over the primary tumor for 45 minutes.~* At 60 minutes post injection, a whole-body PET will be acquired.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PET/CT
Description: * Combined PET and computed tomography (CT) imaging with 68Ga-FAPI-46 will be performed using the same protocol on a Biograph 6 PET/CT scanner (Siemens, Erlangen, Germany) and General Electrics (GE) Discovery 710, Milwaukee, Wisconsin, USA at the Department of Nuclear Medicine, Karolinska Huddinge within 2 weeks before surgery.~* PET/CT imaging will be performed in dynamic mode at one bed position centered over the primary tumor for 45 minutes.~* At 60 minutes post injection, a whole-body PET will be acquired.
Study: NCT05640635

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ventilator weaning first
Description: Ventilator weaning initiated and completed before start of ECMO weaning.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ECMO weaning first
Description: ECMO weaning initiated and completed before start of ventilator weaning.
Study: NCT06500845

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bevel marginal design endocrown for endodontically treated teeth
Description: Bevel marginal design will be prepared for endodontically treated teeth and restores with Peek endocrown

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Butt marginal design endocrown for endodontically treated teeth
Description: Butt marginal design will be prepared for endodontically treated teeth and restores with Peek endocrown
Study: NCT05546060

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax 100mg qd d1，200mg qd d2，400mg qd d3-56

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 10mg/m2 qd d1-14, 5mg/m2 qd d15-28, 2.5 mg/m2 qd d29-42, and 1.25mg/m2 qd43-56

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Etoposide 75mg/m2 qw d1-56
Study: NCT04750239

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivatrotamab
Description: Anti GD2×CD3 monoclonal bi-specific antibody
Study: NCT04205539

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: This medication will be administered sublingually using an LMA Intranasal Mucosal Atomization Device, which allows the medication to be administered in the form of a spray. Patients will be instructed to keep the medication in their mouth for about 2 minutes, or until fully absorbed. Pulse oximetry and blood pressure will be monitored throughout the duration of treatment. After the subject is asleep, the second DTI scan will be done.
Study: NCT05213663

Intervention type: OTHER
Intervention: assessment
Description: To examine the awareness of parents of Cerebral Palsy children about the disease, physiotherapy and rehabilitation.
Study: NCT05210608

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Working Memory Training (Active Intervention) + Behavioral Intervention
Description: Participants will be randomized to complete 10 sessions of a Working Memory Training. All participants will receive behavioral activation (a behavioral intervention for smoking cessation) and nicotine patches.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Training (CT) + Behavioral Intervention
Description: Participants will be randomized to complete 10 sessions of a Control Condition Memory Training. All participants will receive behavioral activation (a behavioral intervention for smoking cessation) and nicotine patches.
Study: NCT05411653

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality training with motor imagery
Description: comprised of 30 minutes, VRT (15 minutes) and MI (15 minutes) daily for 3 days respectively. Five Xbox Kinect gaming will be selected and explained to the patients for the virtual training session and additional 15 minutes will be given to them for practice. The games consists of 20,000 water leaks, river rush, reflex ridge, soccer and football for the patients.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: range of motion exercises, muscle strengthening, functional training, balance training, and gait training. The specific tasks will be selected by the therapist based on the requirement of each patient. It will be performed for 30 minutes for 3 days a week for 6 weeks
Study: NCT04968951

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole
Description: Antibiotic treatment - 250 mg every 6 hrs for 5 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo treatment

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: Antibiotic treatment - 125 mg every 6 hrs for 5 days

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Fecal Microbiota Transplantation
Description: Encapsulated biologically active human fecal material (donor stool) is provided in capsule form. The fecal material is homogenized with sterile saline, then pelleted and re-suspended in sterile saline/40% glycerol. Participants will receive 15 FMT capsules per day for 3 consecutive days. Capsule are to be swallowed under direct supervision.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Fecal Microbiota Transplantation
Description: Encapsulated biologically active human fecal material (donor stool) is provided in capsule form. The fecal material is homogenized with sterile saline, then pelleted and re-suspended in sterile saline/40% glycerol. Participants will receive 15 FMT capsules per day for 3 consecutive days. Capsule are to be swallowed under direct supervision.
Study: NCT05368480

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Senior Companion Program
Description: Receives a companion to socialize with them, help with daily tasks, etc.
Study: NCT05008380

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: prone positioning
Description: 3-6 hours of prone-positioning twice a day
Study: NCT06353932

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: keeping the endotracheal tube cuff pressure within a certain range
Description: The endotracheal tube cuff pressures of the study group patients were kept within the range of 20-25 cm H2O.
Study: NCT05706285

Intervention type: PROCEDURE
Intervention: Regional Block Comparison
Description: Comparing postoperative pain and opioid consumption in groups

Intervention type: PROCEDURE
Intervention: Regional Block Comparison
Description: Comparing postoperative pain and opioid consumption in groups
Study: NCT06539650

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fractal Paced
Description: The intervention consists in a single session of metronome paced strength training composed by 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, synchronizing each repetition with fractal external cues presented by a visual metronome. The rest between sets will be set at 2 minutes of rest between sets.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isochronus Paced
Description: The intervention consists in a single session of metronome paced strength training composed by 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, synchronizing each repetition with isochronus external cues presented by a visual metronome. The rest between sets will be set at 2 minutes of rest between sets.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Paced
Description: The intervention consists in a single session of strength training composed by 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, at at participants' own self pace (with no metronome). The rest between sets will be set at 2 minutes of rest between sets.
Study: NCT05965908

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: liraglutide
Description: glucagon-like peptide 1 receptor agonist

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: biguanide antihyperglycemic
Study: NCT05208892

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SZMN block
Description: Suprazygomatic Maxillary Nerve (SZMN) Blocks bilaterally

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SZMN block with Dexmedetomidine
Description: Suprazygomatic Maxillary Nerve (SZMN) Blocks with local anesthetic and Dexmedetomidine bilaterally
Study: NCT05039541

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Alio Device
Description: Subjects will wear the Alio device over their vasculature.
Study: NCT05885685

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nabilone Oral Capsule
Description: Each oral capsule contains a 0.25 mg dose of nabilone. Participants begin by taking 1 capsule at night then 1 capsule in the morning and 1 at night for the next 2 days. On the 4th day, the dose is doubled. On the 6th day, the dose is doubled again.
Study: NCT04448249

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: APN intervention
Description: APN intervention is divided into five main steps:~* clinical and paraclinical examinations,~* appraisal of patient's knowledge,~* health education on hypertension and treatments,~* setting a written medication plan with the patient to invest him in his management with adjusting or renewing treatments identically if necessary,~* decision-making balance between the benefits and risks of non-adherence to medication. A time is scheduled at the end of the intervention to let the patient ask questions or express his difficulties if he needs to.
Study: NCT04884022

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Miniplates in mandibular symphysis & infrazygomatic
Description: Fixed functional appliance (pushing orthopedic force) in conjunction with direct skeletal anchorage
Study: NCT05656976

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Provision of self sampling device by the GP
Description: In a group of 45 GP practices, over a course of 9 months, all long-term unscreened women with a GMD will be addressed by their GP when they consult for any reason. The GP will discuss the pros and cons of screening for cervical cancer, the various options for screening for cervical cancer including the possibility of using a SSD. For this, the GP can use on accessible brochure and video materials. After the woman agrees, she is given a self-taking kit that she can use when and where it suits her and send it to the lab with the prepaid envelope. The woman is informed of the result of the Human Papilloma Virus test result by her GP according to the usual way in the practice (e.g. via letter, by phone or during the next consultation).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Provision of self sampling device by letter
Description: In the second arm, a second group of 45 GP practices in Flanders will be recruited. With the intervention of the Centre for Cancer Prevention (Flanders), 25 at randomly selected long-term unscreened women with a Global Medical Form (in dutch: 'Globaal Medisch Dossier, GMD) in one of these practices will receive an envelope containing a letter of invitation from their GP for cervical cancer screening, a brochure with the advantages and disadvantages of cervical cancer screening and more specifically the use of a self-taking kit, and a self-taking kit. If the woman wishes, she can use the kit when and where it suits her and send it to the lab with the pre-paid envelope. As in arm A, the woman will be informed of the Human Papilloma Virus test result by her GP according to the usual way in the practice (e.g., by letter, by phone or during the next consultation). All women will receive a study-related reminder letter after 4 months.
Study: NCT04884022

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Miniplates in external oblique ridge & anterior maxillary region
Description: Coil spring (pulling orthopedic force) in conjunction with direct skeletal anchorage
Study: NCT05348928

Intervention type: DEVICE
Intervention: Continuous glucose monitoring device
Description: Continuous glucose monitoring device

Intervention type: DEVICE
Intervention: Continuous glucose monitoring device
Description: Continuous glucose monitoring device

Intervention type: OTHER
Intervention: Laboratory plasma glucose concentration determination
Description: Laboratory plasma glucose concentration determination

Intervention type: OTHER
Intervention: Laboratory plasma glucose concentration determination
Description: Laboratory plasma glucose concentration determination
Study: NCT04777305

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity training
Description: Participants will be randomized into either one of three intervention groups (aerobic training, resistance training, or combined training comprised of resistance and aerobic training) and a control group. Training is described in the arm description section.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity training
Description: Participants will be randomized into either one of three intervention groups (aerobic training, resistance training, or combined training comprised of resistance and aerobic training) and a control group. Training is described in the arm description section.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity training
Description: Participants will be randomized into either one of three intervention groups (aerobic training, resistance training, or combined training comprised of resistance and aerobic training) and a control group. Training is described in the arm description section.
Study: NCT04498858

Intervention type: OTHER
Intervention: Patient interview
Description: Patient will be interviewed :~* tobacco consumption~* reported question asked by the dentist about his/her tobacco consumption~* presence and nature of reported advices given by the dentist~* presence and nature of actions proposed by dentists for patients reporting tobacco consumption, including prescription of NRT~* presence and nature of the actions carried out or envisaged by these patients, including - smoking cessation~* contact with the general practioner~* Fagerstrom score (2 questions)~* demographic variables, age, sex, level of education~* satisfaction
Study: NCT05947643

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: theophylline
Description: capsules dissolved in intranasal irrigation

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: identical-appearing lactose capsules dissolved in intranasal irrigation
Study: NCT05197868

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intubation with traditional laryngoscope
Description: Participants will be invited to intubate the mannequin with a traditional laryngoscope

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intubation with a straight blade video laryngoscope
Description: Intubation with a straight blade video laryngoscope

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intubation with a hyper-angulated video laryngoscope
Description: Participants will be asked to intubate the mannequin with a hyper-angulated video laryngoscope
Study: NCT05734781

Intervention type: OTHER
Intervention: Not Application as this is a qualitative study
Description: Not Application as this is a qualitative study
Study: NCT05014282

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Description: Participants will be provided with a 10-week supply of nicotine patches

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine patch
Description: Participants will be provided with a 10-week supply of nicotine patches

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: Phone counseling with the state tobacco quitline.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Description: Participants will be provided with a 10-week supply of nicotine lozenges